CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Impairment of Intangible Assets, Finite-lived
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Impairment of Intangible Assets, Finite-lived of $210.97 million for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. impairment of intangible assets, finite-lived for the quarter ending 2016-03-26 was $1.90M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. impairment of intangible assets, finite-lived for fiscal 2025 was $210.97M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. impairment of intangible assets, finite-lived for fiscal 2024 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. impairment of intangible assets, finite-lived for fiscal 2023 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. impairment of intangible assets, finite-lived for fiscal 2016 was $1.90M.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|---|
| 2025-12-27 | $210.97M 10-K · filed 2026-02-18 | |
| 2024-12-28 | $0.00 10-K · filed 2026-02-18 | |
| 2023-12-30 | $0.00 10-K · filed 2026-02-18 | |
| 2016-12-31 | $1.90M 10-K · filed 2018-02-13 | |
| 2016-03-26 | $1.90M 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |